Trial NCT00042835

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2012-02478
Secondary IDs: 11432B CDR0000069474 N01CM17102 N01CM62201

Last trial update was posted on 2013-02-01

MeSH Interventions

Carboplatin Docetaxel Erlotinib Hydrochloride Etoposide Etoposide phosphate Paclitaxel

MeSH Conditions

Adenocarcinoma of Lung Adenocarcinoma, Bronchiolo-Alveolar Carcinoma, Non-Small-Cell Lung Lung Neoplasms

Other Conditions

Adenocarcinoma of the Lung Bronchoalveolar Cell Lung Cancer Large Cell Lung Cancer Squamous Cell Lung Cancer Stage IIIA Non-small Cell Lung Cancer Stage IIIB Non-small Cell Lung Cancer

Stopping Reasons

Administratively complete.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID